Montagu Acquires Majority Stake in HTL Biotechnology
February 28, 2022
Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.
- Buyers
- Montagu
- Targets
- HTL Biotechnology
- Sellers
- Bridgepoint
- Industry
- Pharmaceuticals
- Location
- Brittany, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
H&T Presspart Acquires Majority Stake in Plas-Tech Engineering
March 16, 2026
Medical Devices
H&T Presspart, a division of the Heitkamp Thumann Group, acquired a majority stake in Plas-Tech Engineering. The transaction closed in November 2025 and expands H&T Presspart’s manufacturing footprint into the United States by adding Plas-Tech’s medical device manufacturing site in Lake Geneva, Wisconsin.
-
Bridgepoint to Acquire Majority Stake in ht.digital
November 30, 2025
Financial Services
Bridgepoint has agreed to acquire a majority stake in ht.digital, a London-headquartered digital asset assurance provider. The investment will be made via Bridgepoint Development Capital V and is expected to close in the first half of 2026, subject to regulatory approval.
-
HTL Biotechnology Acquires Modern Meadow's Beauty & Biomedical Division
May 6, 2024
Biotechnology
HTL Biotechnology has acquired the beauty and biomedical division of American company Modern Meadow, including its recombinant proteins platform and leading human recombinant collagen type III (rhCOL3) technology. The deal expands HTL's biopolymer portfolio and R&D/manufacturing capabilities, strengthens its presence in North America, and accelerates development of cosmetic and medical-grade recombinant collagen products.
-
Montagu Acquires Stake in Intech (Orthopaedic Medical Device Manufacturer)
July 12, 2021
Medical Devices
Montagu, a European private equity firm, has entered into and closed a strategic investment in Intech, the France-based global leader in contract manufacturing of orthopaedic surgical instruments. The transaction follows negotiations with existing investors Eurazeo PME and Andera Partners and will see Montagu support Intech’s management to accelerate organic and external growth, expand capacity, and strengthen its position in orthopaedics.
-
THG PLC Acquires Bentley Laboratories LLC
May 10, 2021
Manufacturing
THG PLC has agreed to acquire Bentley Laboratories LLC from The Riverside Company and Norgate Holdings. Bentley is a US-based developer and manufacturer of prestige skincare and haircare products with extensive formulation and manufacturing capabilities; the deal strengthens THG's in-house product development and manufacturing for its direct-to-consumer beauty platform and is expected to close following regulatory approval.
-
Edgewater Capital Partners Acquires Haematologic Technologies
October 11, 2019
Biotechnology
Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.